Cargando…
Effectiveness of Prophylactic Coagulation Factor Replacement Therapy in Patients with Severe Hemophilia A in Taiwan – A Population-Based Study
PURPOSE: Taiwan launched reimbursement of prophylactic coagulation factor replacement therapy (CFRT) for patients with severe hemophilia type A (severe PWHA) in 2014. However, since then, the effectiveness of prophylactic CFRT in real-world practice has not been evaluated thoroughly. This study aime...
Autores principales: | Hsieh, Miyuki Hsing-Chun, Chiou, Shyh-Shin, Liao, Tzu-Chi, Lai, Shi-Jie, Lai, Edward Chia-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759011/ https://www.ncbi.nlm.nih.gov/pubmed/36536898 http://dx.doi.org/10.2147/CLEP.S391753 |
Ejemplares similares
-
Clinical Predictors and Prediction Models for rFVIII-Fc Half Life in Real-World People with Severe Hemophilia A
por: Chang, Chia-Yau, et al.
Publicado: (2023) -
Aspects of prophylactic treatment of hemophilia
por: Ljung, Rolf
Publicado: (2016) -
Effects of coagulation factor concentrate prophylaxis in moderate and severe hemophilia A patients at a single hemophilia center in Korea
por: Moon, Byung Suk, et al.
Publicado: (2013) -
Coagulation Factor IX for Hemophilia B Therapy
por: Orlova, N. A., et al.
Publicado: (2012) -
Patient and parent preferences for characteristics of prophylactic treatment in hemophilia
por: Furlan, Roberto, et al.
Publicado: (2015)